Locht, Camille https://orcid.org/0000-0001-7295-7336
Article History
Received: 4 December 2024
Revised: 22 January 2025
Accepted: 23 January 2025
First Online: 24 February 2025
Disclosure and competing interests statement
: Camille Locht is the co-inventor of BPZE1, and its employer holds a patent folio on the technology, currently licensed to ILiAD Biotechnologies. He also reports consulting fees from, and holds equity in ILiAD Biotechnologies.